60 related articles for article (PubMed ID: 8506953)
1. The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice?
Panebianco M; Ciccarese C; Strusi A; Beccia V; Carbone C; Agostini A; Piro G; Tortora G; Iacovelli R
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339243
[TBL] [Abstract][Full Text] [Related]
2. C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis.
Korsten P; Baier E; Hakroush S; Tampe B
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834488
[TBL] [Abstract][Full Text] [Related]
3. Complement C4, Infections, and Autoimmune Diseases.
Wang H; Liu M
Front Immunol; 2021; 12():694928. PubMed ID: 34335607
[TBL] [Abstract][Full Text] [Related]
4. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
[TBL] [Abstract][Full Text] [Related]
5. Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets.
Han X; de la Fuente M; Nieman MT
Res Pract Thromb Haemost; 2021 Jan; 5(1):104-110. PubMed ID: 33537534
[TBL] [Abstract][Full Text] [Related]
6. Complement System Part I - Molecular Mechanisms of Activation and Regulation.
Merle NS; Church SE; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2015; 6():262. PubMed ID: 26082779
[TBL] [Abstract][Full Text] [Related]
7. Complement System Part II: Role in Immunity.
Merle NS; Noe R; Halbwachs-Mecarelli L; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2015; 6():257. PubMed ID: 26074922
[TBL] [Abstract][Full Text] [Related]
8. C4a: An Anaphylatoxin in Name Only.
Barnum SR
J Innate Immun; 2015; 7(4):333-9. PubMed ID: 25659340
[TBL] [Abstract][Full Text] [Related]
9. Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice.
Dang L; He L; Wang Y; Xiong J; Bai B; Li Y
Mol Med Rep; 2015 Jun; 11(6):4183-9. PubMed ID: 25650554
[TBL] [Abstract][Full Text] [Related]
10. Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury.
Zhao Y; Xu H; Yu W; Xie BD
Mol Med Rep; 2014 Jul; 10(1):45-52. PubMed ID: 24789665
[TBL] [Abstract][Full Text] [Related]
11. Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.
Wiederin JL; Donahoe RM; Anderson JR; Yu F; Fox HS; Gendelman HE; Ciborowski PS
J Proteome Res; 2010 Sep; 9(9):4721-31. PubMed ID: 20677826
[TBL] [Abstract][Full Text] [Related]
12. Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.
Soto E; Romero R; Richani K; Yoon BH; Chaiworapongsa T; Vaisbuch E; Mittal P; Erez O; Gotsch F; Mazor M; Kusanovic JP
J Matern Fetal Neonatal Med; 2009 Nov; 22(11):983-92. PubMed ID: 19900036
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome.
Sorensen B; Jones JF; Vernon SD; Rajeevan MS
Mol Med; 2009; 15(1-2):34-42. PubMed ID: 19015737
[TBL] [Abstract][Full Text] [Related]
14. Switch moiety in agonist/antagonist dual effect of S19 ribosomal protein dimer on leukocyte chemotactic C5a receptor.
Shrestha A; Shiokawa M; Nishimura T; Nishiura H; Tanaka Y; Nishino N; Shibuya Y; Yamamoto T
Am J Pathol; 2003 Apr; 162(4):1381-8. PubMed ID: 12651630
[TBL] [Abstract][Full Text] [Related]
15. Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease.
Laufer J; Oren R; Goldberg I; Horwitz A; Kopolovic J; Chowers Y; Passwell JH
Clin Exp Immunol; 2000 Apr; 120(1):30-7. PubMed ID: 10759760
[TBL] [Abstract][Full Text] [Related]
16. Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis.
Tsuruta T; Yamamoto T; Matsubara S; Nagasawa S; Tanase S; Tanaka J; Takagi K; Kambara T
Am J Pathol; 1993 Jun; 142(6):1848-57. PubMed ID: 8506953
[TBL] [Abstract][Full Text] [Related]
17. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
[TBL] [Abstract][Full Text] [Related]
18. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
Goetzl EJ; Rocklin RE
J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
[TBL] [Abstract][Full Text] [Related]
19. Secretion of monocyte chemotactic protein-1 by human uterine epithelium directs monocyte migration in culture.
Meter RA; Wira CR; Fahey JV
Fertil Steril; 2005 Jul; 84(1):191-201. PubMed ID: 16009177
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
